Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • September 22, 2024

Tangri N, Rastogi A, Sofue T. Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Sep 19. doi: 10.1007/s12325-024-02961-3. Epub ahead of print. PMID: 39298075.

Tags: albuminuria, Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT-2i, Urinary albumin-to-creatinine ratio

The Role of Precision Nutrition in Kidney Disease

Narasaki Y, Rhee CM, Li Z. The Role of Precision Nutrition in Kidney Disease. Clin J Am Soc Nephrol. 2025 Jul 1. doi: 10.2215/CJN.0000000807. Epub[...]

The Association of Antiemetics Use with Incident Chronic Kidney Disease

Kalantar DS, Takahashi R, Shen JI, Tran D, Ismail A, Pena EL, Abichequer-Beer M, Thomas F, Lu JL, Sumida K, Kalantar-Zadeh K, Kovesdy CP, Rhee[...]

Managing Patients with Hyperchloremia

Nagami GT. Managing Patients with Hyperchloremia. Clin J Am Soc Nephrol. 2025 Jun 30. doi: 10.2215/CJN.0000000806. Epub ahead of print. PMID: 40587230.